UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

The role of interleukin-10 in suppression of Mycobacterium tuberculosis infection and BCG vaccination in resistant and susceptible mouse strains

Pitt, JM; (2012) The role of interleukin-10 in suppression of Mycobacterium tuberculosis infection and BCG vaccination in resistant and susceptible mouse strains. Doctoral thesis , UCL (University College London).

Full text not available from this repository.

Abstract

Tuberculosis, caused by infection with the intracellular pathogen Mycobacterium tuberculosis, remains a major global threat to humanity. BCG remains the only prophylactic vaccine against tuberculosis but gives variable protection against pulmonary disease. While it is unclear what determines an effective immune response against Mycobacterium tuberculosis infection, the generation of host Th1 responses is accepted to be a major mechanism of protection; and promoting earlier and enhanced Th1 responses may increase the efficacy of tuberculosis vaccines. Early production of interleukin-17 in the lungs following Mycobacterium tuberculosis challenge of previously vaccinated mice has been shown to be required for efficient Th1 cell recruitment. Interleukin-10 is an immunosuppressive cytokine that regulates various processes involved in the generation of both Th1 and Th17 responses. The investigations within this thesis extend on previous studies showing interleukin-10 negatively regulates the immune response to primary Mycobacterium tuberculosis infection. Firstly, these investigations show that interleukin-10 signalling inhibits host control of infection with virulent and hypervirulent Mycobacterium tuberculosis strains, in both Mycobacterium tuberculosis-resistant C57BL/6 mice, and Mycobacterium tuberculosis-susceptible CBA/J mice. Furthermore, inhibition of interleukin-10 signalling specifically during BCG vaccination enhanced host-generated antigen-specific interferon-γ and interleukin-17 responses, and this regime gave significantly greater protection against aerogenic Mycobacterium tuberculosis challenge in both mouse strains. In susceptible CBA/J mice, antibody blockade of interleukin-10 receptor specifically during BCG vaccination resulted in an unprecedented 1-Log10 further protection against Mycobacterium tuberculosis challenge as compared to BCG-vaccination alone. This robust protection was sustained during the course of Mycobacterium tuberculosis infection, and correlated with superior lung Th1 and Th17 responses, and enhanced interferon-γ and interleukin-17 production from innate lymphoid cells. In summary, interleukin-10 inhibits both host-mediated protection against primary Mycobacterium tuberculosis infection, and optimal BCG-elicited protection. Antagonists of interleukin-10 may therefore be greatly beneficial as adjuncts to tuberculosis therapy, and as adjuvants in preventive vaccination against tuberculosis.

Type: Thesis (Doctoral)
Title: The role of interleukin-10 in suppression of Mycobacterium tuberculosis infection and BCG vaccination in resistant and susceptible mouse strains
Language: English
Additional information: Permission for digitisation not received
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
URI: http://discovery.ucl.ac.uk/id/eprint/1365866
Downloads since deposit
3Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item